Nationwide Hepatitis B Screening Campaign Launched on World Hepatitis Day

Cipla and INASL Launch Nationwide Hepatitis B Screening Campaign on World Hepatitis Day

On World Hepatitis Day, celebrated on July 28, Cipla, a leading pharmaceutical company, in collaboration with the Indian National Association for the Study of the Liver (INASL), initiated a comprehensive nationwide screening campaign for Hepatitis B. This campaign aims to increase awareness and promote early detection of the virus, which affects millions globally. Hepatitis B is a viral infection that can lead to chronic liver disease, cirrhosis, and liver cancer if left untreated.

Importance of Early Screening

Experts from AIIMS (All India Institute of Medical Sciences) emphasize that early screening is crucial in preventing fatalities associated with hepatitis. They highlighted that a significant proportion of individuals living with Hepatitis B are unaware of their condition, making screening initiatives particularly vital.

Broader Efforts in Indias Fight Against Hepatitis

The Indian government has been actively working to combat hepatitis through various health initiatives, including awareness campaigns and vaccination programs. The Ministry of Health reported that over 21 crore people have been screened for hepatitis as a part of their ongoing efforts.

Understanding the Silent Epidemic

World Hepatitis Day serves as a reminder of the challenges posed by hepatitis, often referred to as a silent epidemic. Many individuals exhibit no symptoms in the early stages of the disease, which can lead to delayed treatment. Health professionals urge the public to recognize warning signs and seek medical advice if they suspect they may be at risk.

For more detailed information on hepatitis and the significance of screening, the public can refer to credible health resources and consult healthcare professionals.